Events

Global views, local problems: Innovative solutions to AMR and infection challenges. The British Society for Antimicrobial Chemotherapy (BSAC) 2019 Spring Conference offers a state of the art overview of the infection management and antimicrobial resistance landscape. The programme includes keynote lectures, plenary and parallel sessions, debates and an opening series of spotlight presentations – offering […]

Speakers include Kevin Outterson, CARB-X Executive Director. The Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an […]

Speakers include Karen Gallant, CARB-X Global Project Director. The 1st Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical development of effective phage therapy. Join the leaders in phage therapy product development as they discuss the latest data-driven case […]

Speakers include Kevin Outterson, CARB-X Executive Director. Join 120+ health policy leaders, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control, before it is too late. A series of expert panel discussions will dig into the topics that matter the most, using the convening power […]

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. The webinar will be held from 5:00 pm – 6:30 […]

...from European life science companies until May 10. Information about how to apply can be found at here. The REPAIR Impact Fund is now open for investment proposals from European life science companies targeting AMR. Companies are invited to submit a non-confidential proposal, which will be evaluated during the spring. Successful projects will be invited […]

ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 12,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, […]

Speakers include Dr. Barry Eisenstein, Chair of the CARB-X Advisory Board. For the past 18 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with:  300 speakers, 1500 attendees and hundreds of networking opportunities.  This year's congress will feature a variety of  pre-congress workshops and conferences in: Cancer Immunotherapy Immune Profiling Respiratory Vaccines Emerging […]

It is generally recognized that control and prevention of antimicrobial resistance (AMR) requires a holistic One Health approach involving specialists from different sectors. In line with this concept, the 2nd ICOHAR aims to bring together representatives from all relevant sectors (e.g. public health, human and veterinary medicine, livestock production, food safety and environmental sciences) to share […]

This conference is designed for physicians, infection preventionists, healthcare epidemiologists, infectious disease specialists, microbiologists, nurses, pharmacists, and other healthcare professionals interested in healthcare epidemiology, infection prevention, Antimicrobial Stewardship, surveillance, research methods, patient safety, environmental issues, and quality improvement. The SHEA 2019 Program Committee combines the expertise of SHEA members who have served on SHEA meeting […]